Tenders Are Invited For Pharmaceutical Products

Contract Notice Pharmaceutical ProductsConclusion Of Framework Agreements For The Period 1 1 2020 To 31 12 2021 Through The Electronic System For The Purchase Of Antitumor Medicinal Products For The Needs Of Medical Establishments In The Republic Of BulgariaDescription B02bx04 Romiplostim Parenteral Mcg 1978000 B02bx05 Eltrombopag Oral Solid Mg 2545800 B03xa01 Erythropoietin Epoetin Alfa Parenteral Iu 1440363640 B03xa01 Erythropoietin Epoetin Beta Parenteral Iu 581226800 B03xa01 Erythropoietin Epoetin Zeta Parenteral Iu 394183200 B03xa02 Darbepoetin Alfa Parenteral Mcg 3047186 B03xa03 Methoxy Polyethylene Glycol Epoetin Beta Parenteral Mcg 619875 H01cb02 Octreotide Parenteral Mg 122604 Powder And Solvent For Suspension For Injection H02ab02 Dexamethasone Parenteral Mg 11868994 J06ba02 Immunoglobulins Normal Human For Intravascular Adm Parenteral Mg 24526250 50 Mg Ml J06ba02 Immunoglobulins Normal Human For Intravascular Adm Parenteral Mg 32838000 100Mg Ml L01aa01 Cyclophosphamide Parenteral Mg 39039322 L01aa02 Chlorambucil Oral Solid Mg 230212 L01aa06 Ifosfamide Parenteral Mg 28479000 L01aa09 Bendamustine Parenteral Mg 1163000 L01ax03 Temozolomide Oral Solid Mg 7759180 L01ba04 Pemetrexed Parenteral Mg 3516200 L01bb02 Mercaptopurine Oral Solid Mg 4478600 L01bb05 Fludarabine Parenteral Mg 162300 L01bb06 Clofarabine Parenteral Mg 18720 L01bb07 Nelarabine Parenteral Mg 240500 L01bc01 Cytarabine Parenteral Mg 10835000 Solution For Injection 50 Mg Ml L01bc01 Cytarabine Parenteral Mg 3000 Suspension For Injection 50 Mg Ml L01bc01 Cytarabine Parenteral Mg 3300000 Solution For Injection Infusion 100 Mg Ml L01bc02 Fluorouracil Parenteral Mg 196701131 L01bc05 Gemcitabine Parenteral Mg 38262600 L01bc06 Capecitabine Oral Solid Mg 846635700 L01bc07 Azacitidine Parenteral Mg 1669200 L01bc53 Tegafur Gimeracil Oteracil Oral Solid Tabl 53500 20 Mg 5 8 Mg 15 8 Mg L01bc59 Trifluridine Tipiracil Oral Solid Tab 38680 15 Mg 6 14 Mg L01bc59 Trifluridine Tipiracil Oral Solid Tab 108920 20 Mg 8 19 Mg L01ca04 Vinorelbine Parenteral Mg 382310 L01cb01 Etoposide Parenteral Mg 6152528 L01cd01 Paclitaxel Parenteral Mg 7815272 L01cd02 Docetaxel Parenteral Mg 2908264 L01cd04 Cabazitaxel Parenteral Mg 90032 L01db01 Doxorubicin Parenteral Mg 274400 Concentrate For Solution For Infusion L01db01 Doxorubicin Parenteral Mg 127780 Powder Dispersion And Solvent For Concentrate For Dispersion For Infusion L01db03 Epirubicin Parenteral Mg 4138050 L01db06 Idarubicin Parenteral Mg 26425 L01db07 Mitoxantrone Parenteral Mg 48036 L01db11 Pixantrone Parenteral Mg 93312 L01xa01 Cisplatin Parenteral Mg 2667680 L01xa02 Carboplatin Parenteral Mg 9604450 L01xa03 Oxaliplatin Parenteral Mg 4881154 L01xco2 Rituximab Parenteral Mg 6128000 Concentrate For Solution For Infusion Icd C82 C83 C91 M31 L01xc02 Rituximab Parenteral Mg 4417000 Solution For Injection L01xc03 Trastuzumab Parenteral Mg 4033140 Powder For Concentrate For Solution For Infusion L01xc03 Trastuzumab Parenteral Mg 8816640 Solution For Injection L01xc06 Cetuximab Parenteral Mg 4154934 L01xc07 Bevacizumab Parenteral Mg 24423280 L01xc08 Panitumumab Parenteral Mg 1704120 L01xc11 Ipilimumab Parenteral Mg 86530 L01xc12 Brentuximab Vedotin Parenteral Mg 114950 L01xc13 Pertuzumab Parenteral Mg 3571900 L01xc14 Trastuzumab Emtansine Parenteral Mg 645280 L01xc15 Obinutuzumab Parenteral Mg 1254000 L01xc17 Nivolumab Parenteral Mg 639460 L01xc18 Pembrolizumab Parenteral Mg 1602400 L01xc19 Blinatumomab Parenteral Mcg 22676 L01xc21 Ramucirumab Parenteral Mg 1324654 L01xc24 Daratumumab Parenteral Mg 1957000 L01xc26 Inotuzumab Ozogamicin Parenteral Mg 213 L01xc27 Olaratumab Parenteral Mg 1202890 L01xc32 Atezolizumab Parenteral Mg 7882400 Continued In Section Ii 2 14 Further Information Time Limit For Receipt Of Tenders Or Requests To Participate Date 08 10 2019 Local Time 23 59 Disclaimer The Above Text Is Machine Translated For Accurate Information Kindly Refer The Original Document

Refer document